United States· US:72694-879_ee016d13-6ef7-4e50-bb23-d8ece41d549d
VORANIGO
A vorasidenib product containing vorasidenib, registered in United States by Servier Pharmaceuticals LLC. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Vorasidenib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01XM04 (vorasidenib), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Vorasidenib · ATC L01XM04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VORASIDENIB
- Manufacturer
- Servier Pharmaceuticals LLC
- Country
- United States (US)
- ATC code
- L01XM04
- ATC class
- Vorasidenib
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1172694-879-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vorasidenib in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVORANIGO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULALes Laboratoires Servier
- FranceVORANIGO 10 mg, comprimé pelliculéLES LABORATOIRES SERVIER
- NetherlandsVoranigo 10 mg filmomhulde tablettenLes Laboratoires Servier
- SwitzerlandVoranigo 10 mg, comprimés pelliculésServier (Suisse) SA
- PolandVoranigoLes Laboratoires Servier
- SwedenVoranigo 10 mg Filmdragerad tablettLes Laboratoires Servier
- NorwayVoranigoLes Laboratoires Servier
- United KingdomVoranigo 10mg tabletsServier Laboratories Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voranigo
- Liechtenstein · Voranigo
- Norway · Voranigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f0808ad-1e37-40ae-a6a6-6cb20a9c66a3 GET /v1/drugs/6f0808ad-1e37-40ae-a6a6-6cb20a9c66a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "VORASIDENIB",
"productndc": "72694-879",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA218784",
"marketing_category": "NDA"
}See everything about vorasidenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.